Endo to Acquire Specialty Pharmaceutical Company Paladin Labs

05-11-2013 PR NewswireComments (0)

Endo Health SolutionsPaladin LabsPharmaceutical

Endo Health Solutions (NASDAQ: ENDP) ("Endo") today announced that it has reached a definitive agreement to acquire Paladin Labs Inc. (TSX: PLB), ("Paladin Labs") a leading Canada-based specialty pharmaceutical company, in a stock and cash ...

Read more on PR Newswire

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top